Clinical Trial Update: Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating targeted axillary lymph node dissection in node-positive breast cancer patients after neoadjuvant therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Assiut University | Conditions: Node-positive Breast Cancer | Phase 4 | Status: UNKNOWN